Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation TCT 2014

Pulmonary Artery Denervation for Pulmonary Hypertension: Results, Case Example, and Future Directions

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Shao Liang Chen

September 14, 2014

Presentation TCT 2014

Alternative Device-Based Modalities to Treat Hypertension

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Paul A. Sobotka

September 14, 2014

Presentation TCT 2014

A Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension (Vascular Dynamics)

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Mark C. Bates

September 14, 2014

Presentation TCT 2014

TCT 404: First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi

September 14, 2014

Presentation TCT 2014

Transureteral Pelvic Denervation

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Richard R. Heuser

September 14, 2014

Presentation TCT 2014

Renal Denervation for Chronic Kidney Disease: Status and Case Example

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Felix Mahfoud

September 14, 2014

Presentation TCT 2014

Renal Denervation for Congestive Heart Failure: Status and Case Example

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Justin E. Davies

September 14, 2014

Presentation TCT 2014

Renal Denervation for Atrial and Ventricular Arrhythmias: Status and Case Examples

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Vivek Y. Reddy

September 14, 2014

Presentation TCT 2014

Extravascular Focused Ultrasound for Renal Denervation: Kona Medical Update

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, John A. Ormiston

September 14, 2014

Presentation TCT 2014

Second Deep Dive into SYMPLICITY HTN-3: Novel Mechanistic Insights from the Trial

Presenter: David Kandzari

September 14, 2014

Presentation TCT 2014

Is Renal Denervation a Blockbuster Therapy or Have We Ground to a Halt?

Presenter: Jose Luis Assad-Morell, Efrain Gaxiola, Armando Tellez

September 13, 2014

Presentation TCT 2013

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Presenter: Horst Sievert

October 28, 2013

Presentation TCT 2013

Veropaque, A Novel Contrast Formulation, Mitigates Contrast Induced Acute Kidney Injury

Presenter: Sangita Biswas, Elizabeth Rowe, Gerold Mosher, Lovella Insisienmay, Marlies Ozias, Michael Gralinski, Vernon Rowe

January 31, 2013

Advertisement

Pulmonary Artery Denervation for Pulmonary Hypertension: Results, Case Example, and Future Directions

Alternative Device-Based Modalities to Treat Hypertension

A Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension (Vascular Dynamics)

TCT 404: First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

Transureteral Pelvic Denervation

Renal Denervation for Chronic Kidney Disease: Status and Case Example

Renal Denervation for Congestive Heart Failure: Status and Case Example

Renal Denervation for Atrial and Ventricular Arrhythmias: Status and Case Examples

Extravascular Focused Ultrasound for Renal Denervation: Kona Medical Update

Second Deep Dive into SYMPLICITY HTN-3: Novel Mechanistic Insights from the Trial

Is Renal Denervation a Blockbuster Therapy or Have We Ground to a Halt?

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Veropaque, A Novel Contrast Formulation, Mitigates Contrast Induced Acute Kidney Injury

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content